Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,757 | 37,320 | 18,575 | 31,013 | 29,854 |
| Receivables | 233 | N/A | 17 | N/A | 131 |
| Inventories | 722 | 459 | 506 | 642 | 679 |
| Other current assets | 10,945 | 934 | 995 | 1,385 | 1,440 |
| TOTAL | $44,685 | $44,403 | $25,243 | $37,777 | $37,394 |
| Non-Current Assets | |||||
| PPE Net | 175 | 249 | 324 | 399 | 475 |
| Other Non-Current Assets | 56 | 140 | 222 | 390 | 469 |
| TOTAL | $231 | $389 | $546 | $789 | $944 |
| Total Assets | $44,916 | $44,792 | $25,789 | $38,566 | $38,338 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 24,931 | 16,823 | 11,216 | 5,608 | N/A |
| Accounts payable and accrued liabilities | 14,839 | 16,398 | 16,814 | 15,569 | 16,097 |
| Accrued Expenses | 4,341 | 4,363 | 5,090 | 3,986 | 5,762 |
| Other current liabilities | 9,815 | 220 | 256 | 383 | 374 |
| TOTAL | $53,926 | $37,804 | $33,376 | $25,546 | $22,233 |
| Non-Current Liabilities | |||||
| Long Term Debt | 84,663 | 92,302 | 97,469 | 99,918 | 102,508 |
| Other Non-Current Liabilities | 1,790 | 3,605 | 2,611 | 3,274 | 6,698 |
| TOTAL | $86,453 | $95,907 | $100,080 | $103,192 | $109,206 |
| Total Liabilities | $140,379 | $133,711 | $133,456 | $128,738 | $131,439 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,075 | 21,869 | 14,557 | 6,056 | 5,486 |
| Common Shares | 76 | 73 | 60 | 59 | 49 |
| Retained earnings | -720,094 | -707,549 | -676,638 | -657,451 | -650,197 |
| TOTAL | $-95,463 | $-88,919 | $-107,667 | $-90,172 | $-93,101 |
| Total Liabilities And Equity | $44,916 | $44,792 | $25,789 | $38,566 | $38,338 |